Fundz

Aptatek Biosciences, Inc. Completes $4 Million Seed Funding Led By Ip Group, Inc. To Develop Advanced In-Home Monitoring Of Chronic Disease

PRIVATEMar 16, 2022

Amount Raised

$4 Million

Round Type

Seed

PrincetonBiotechnologyHealth Care

Description

Aptatek BioSciences, Inc., a developer of in-home health monitoring solutions for patients with chronic disease, announced the completion of a $4 million seed funding round led by hard science investment firm IP Group, Inc., Canterbury Scientific Limited, a leading global OEM developer and supplier of In Vitro Diagnostic (IVD) test consumables, and the National PKU Alliance (NPKUA) also participated in the round.

Quick answer

Aptatek BioSciences raised $4 Million in a Seed round, dated March 16, 2022. Aptatek BioSciences is based in Princeton, New Jersey, United States.

How much did Aptatek BioSciences raise?
Aptatek BioSciences raised $4 Million in a Seed round on March 16, 2022.
What does Aptatek BioSciences do?
Aptatek BioSciences, Inc. is a point-of-care technology company spinout from Columbia University.
Where is Aptatek BioSciences based and how big is it?
Aptatek BioSciences is based in Princeton, New Jersey, United States. Fundz records about 4 employees.
Who are the decision-makers at Aptatek BioSciences?
Fundz holds 1 contact at Aptatek BioSciences. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who to call at Aptatek BioSciences, and when

A new round usually means Aptatek BioSciences is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Aptatek BioSciences raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Aptatek BioSciences, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Aptatek BioSciences. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Aptatek BioSciences

Location

Princeton, New Jersey, United States

About

Aptatek BioSciences, Inc. is a point-of-care technology company spinout from Columbia University. They are focused on developing in-home health monitoring solutions for patients with chronic diseases, with a particular emphasis on phenylketonuria (PKU). Their groundbreaking in-home monitoring platform aims to address the critical unmet need for PKU management.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Aptatek BioSciences raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for Aptatek BioSciences's next move

See what Strategic adds

Aptatek BioSciences raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.